Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

$ 4.50

4.8
(440)
In stock
Description

Update on management of midgut neuroendocrine tumors

JCM, Free Full-Text

Gastrointestinal Carcinoid Tumours: A Review

New treatments and therapeutic targets for IBS and other

The role of serotonin inhibition within the treatment of carcinoid

JCM, Free Full-Text

Graph Attention Networks for Drug Combination Discovery: Targeting

Fibrosis and carcinoid syndrome: from causation to future therapy

JCM, Free Full-Text

Telotristat ethyl: proof of principle and the first oral agent in

PDF) What Gastroenterologists Should Know about Carcinoid Syndrome

Management of Diarrhea in Patients With Carcinoid Syndrome